デュシェンヌ型筋ジストロフィーのグローバル市場2021

• 英文タイトル：Global Duchenne Muscular Dystrophy Sales Market Report 2021

• レポートコード：QAF27660
• 出版社/出版日：QYResearch / 2021年4月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、136ページ
• 納品方法：Eメール（即日納品）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本市場調査資料では、世界のデュシェンヌ型筋ジストロフィー市場について種類別（デフラザコート、プレドニゾン、その他）、用途別（男性用、女性用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・デュシェンヌ型筋ジストロフィー市場の概要
・世界の主要地域別デュシェンヌ型筋ジストロフィー市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のデュシェンヌ型筋ジストロフィー市場規模2016-2021：種類別（デフラザコート、プレドニゾン、その他）
・世界のデュシェンヌ型筋ジストロフィー市場予測2012-2027：種類別（デフラザコート、プレドニゾン、その他）
・世界のデュシェンヌ型筋ジストロフィー市場規模2016-2021：用途別（男性用、女性用）
・世界のデュシェンヌ型筋ジストロフィー市場予測2012-2027：用途別（男性用、女性用）
・デュシェンヌ型筋ジストロフィーのアメリカ市場規模と予測2016-2021
・デュシェンヌ型筋ジストロフィーのヨーロッパ市場規模と予測2016-2021
・デュシェンヌ型筋ジストロフィーの中国市場規模と予測2016-2021
・デュシェンヌ型筋ジストロフィーの日本市場規模と予測2016-2021
・デュシェンヌ型筋ジストロフィーの東南アジア市場規模と予測2016-2021
・デュシェンヌ型筋ジストロフィーのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報：事業概要・売上・企業動向
（PTC Therapeutics、Sarepta Therapeutics、Others）
・デュシェンヌ型筋ジストロフィーの製造コスト分析
・販売チャネル、流通業者、顧客
・デュシェンヌ型筋ジストロフィーの市場動向・機会・課題
・調査の結論

uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys’ respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The classification of duchenne muscular dystrophy includes deflazacort, prednisone and others. And the proportion of deflazacort in 2017 is about 44%.

Market Analysis and Insights: Global Duchenne Muscular Dystrophy Market
The global Duchenne Muscular Dystrophy market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Duchenne Muscular Dystrophy Scope and Market Size
The global Duchenne Muscular Dystrophy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Duchenne Muscular Dystrophy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Deflazacort
Prednisone
Others

Segment by Application
Male
Female

The Duchenne Muscular Dystrophy market is analysed and market size information is provided by regions (countries). Segment by Application, the Duchenne Muscular Dystrophy market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
PTC Therapeutics
Sarepta Therapeutics
Others

レポート目次

1 Duchenne Muscular Dystrophy Market Overview
1.1 Duchenne Muscular Dystrophy Product Scope
1.2 Duchenne Muscular Dystrophy Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Sales by Type (2016 & 2021 & 2027)
1.2.2 Deflazacort
1.2.3 Prednisone
1.2.4 Others
1.3 Duchenne Muscular Dystrophy Segment by Application
1.3.1 Global Duchenne Muscular Dystrophy Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Male
1.3.3 Female
1.4 Duchenne Muscular Dystrophy Market Estimates and Forecasts (2016-2027)
1.4.1 Global Duchenne Muscular Dystrophy Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Duchenne Muscular Dystrophy Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Duchenne Muscular Dystrophy Price Trends (2016-2027)

2 Duchenne Muscular Dystrophy Estimates and Forecasts by Region
2.1 Global Duchenne Muscular Dystrophy Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Duchenne Muscular Dystrophy Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Duchenne Muscular Dystrophy Sales Market Share by Region (2016-2021)
2.2.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2016-2021)
2.3 Global Duchenne Muscular Dystrophy Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Duchenne Muscular Dystrophy Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Duchenne Muscular Dystrophy Estimates and Projections (2016-2027)
2.4.2 Europe Duchenne Muscular Dystrophy Estimates and Projections (2016-2027)
2.4.3 China Duchenne Muscular Dystrophy Estimates and Projections (2016-2027)
2.4.4 Japan Duchenne Muscular Dystrophy Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Duchenne Muscular Dystrophy Estimates and Projections (2016-2027)
2.4.6 India Duchenne Muscular Dystrophy Estimates and Projections (2016-2027)
3 Global Duchenne Muscular Dystrophy Competition Landscape by Players
3.1 Global Top Duchenne Muscular Dystrophy Players by Sales (2016-2021)
3.2 Global Top Duchenne Muscular Dystrophy Players by Revenue (2016-2021)
3.3 Global Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Duchenne Muscular Dystrophy as of 2020)
3.4 Global Duchenne Muscular Dystrophy Average Price by Company (2016-2021)
3.5 Manufacturers Duchenne Muscular Dystrophy Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Duchenne Muscular Dystrophy Market Size by Type
4.1 Global Duchenne Muscular Dystrophy Historic Market Review by Type (2016-2021)
4.1.1 Global Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021)
4.1.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2016-2021)
4.1.3 Global Duchenne Muscular Dystrophy Price by Type (2016-2021)
4.2 Global Duchenne Muscular Dystrophy Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Duchenne Muscular Dystrophy Sales Forecast by Type (2022-2027)
4.2.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Type (2022-2027)
4.2.3 Global Duchenne Muscular Dystrophy Price Forecast by Type (2022-2027)
5 Global Duchenne Muscular Dystrophy Market Size by Application
5.1 Global Duchenne Muscular Dystrophy Historic Market Review by Application (2016-2021)
5.1.1 Global Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021)
5.1.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2016-2021)
5.1.3 Global Duchenne Muscular Dystrophy Price by Application (2016-2021)
5.2 Global Duchenne Muscular Dystrophy Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Duchenne Muscular Dystrophy Sales Forecast by Application (2022-2027)
5.2.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Application (2022-2027)
5.2.3 Global Duchenne Muscular Dystrophy Price Forecast by Application (2022-2027)

6 North America Duchenne Muscular Dystrophy Market Facts & Figures
6.1 North America Duchenne Muscular Dystrophy Sales by Company
6.1.1 North America Duchenne Muscular Dystrophy Sales by Company (2016-2021)
6.1.2 North America Duchenne Muscular Dystrophy Revenue by Company (2016-2021)
6.2 North America Duchenne Muscular Dystrophy Sales Breakdown by Type
6.2.1 North America Duchenne Muscular Dystrophy Sales Breakdown by Type (2016-2021)
6.2.2 North America Duchenne Muscular Dystrophy Sales Breakdown by Type (2022-2027)
6.3 North America Duchenne Muscular Dystrophy Sales Breakdown by Application
6.3.1 North America Duchenne Muscular Dystrophy Sales Breakdown by Application (2016-2021)
6.3.2 North America Duchenne Muscular Dystrophy Sales Breakdown by Application (2022-2027)

7 Europe Duchenne Muscular Dystrophy Market Facts & Figures
7.1 Europe Duchenne Muscular Dystrophy Sales by Company
7.1.1 Europe Duchenne Muscular Dystrophy Sales by Company (2016-2021)
7.1.2 Europe Duchenne Muscular Dystrophy Revenue by Company (2016-2021)
7.2 Europe Duchenne Muscular Dystrophy Sales Breakdown by Type
7.2.1 Europe Duchenne Muscular Dystrophy Sales Breakdown by Type (2016-2021)
7.2.2 Europe Duchenne Muscular Dystrophy Sales Breakdown by Type (2022-2027)
7.3 Europe Duchenne Muscular Dystrophy Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Duchenne Muscular Dystrophy Market Facts & Figures
8.1 China Duchenne Muscular Dystrophy Sales by Company
8.1.1 China Duchenne Muscular Dystrophy Sales by Company (2016-2021)
8.1.2 China Duchenne Muscular Dystrophy Revenue by Company (2016-2021)
8.2 China Duchenne Muscular Dystrophy Sales Breakdown by Type
8.2.1 China Duchenne Muscular Dystrophy Sales Breakdown by Type (2016-2021)
8.2.2 China Duchenne Muscular Dystrophy Sales Breakdown by Type (2022-2027)
8.3 China Duchenne Muscular Dystrophy Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Duchenne Muscular Dystrophy Market Facts & Figures
9.1 Japan Duchenne Muscular Dystrophy Sales by Company
9.1.1 Japan Duchenne Muscular Dystrophy Sales by Company (2016-2021)
9.1.2 Japan Duchenne Muscular Dystrophy Revenue by Company (2016-2021)
9.2 Japan Duchenne Muscular Dystrophy Sales Breakdown by Type
9.2.1 Japan Duchenne Muscular Dystrophy Sales Breakdown by Type (2016-2021)
9.2.2 Japan Duchenne Muscular Dystrophy Sales Breakdown by Type (2022-2027)
9.3 Japan Duchenne Muscular Dystrophy Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Duchenne Muscular Dystrophy Market Facts & Figures
10.1 Southeast Asia Duchenne Muscular Dystrophy Sales by Company
10.1.1 Southeast Asia Duchenne Muscular Dystrophy Sales by Company (2016-2021)
10.1.2 Southeast Asia Duchenne Muscular Dystrophy Revenue by Company (2016-2021)
10.2 Southeast Asia Duchenne Muscular Dystrophy Sales Breakdown by Type
10.2.1 Southeast Asia Duchenne Muscular Dystrophy Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Duchenne Muscular Dystrophy Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Duchenne Muscular Dystrophy Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Duchenne Muscular Dystrophy Market Facts & Figures
11.1 India Duchenne Muscular Dystrophy Sales by Company
11.1.1 India Duchenne Muscular Dystrophy Sales by Company (2016-2021)
11.1.2 India Duchenne Muscular Dystrophy Revenue by Company (2016-2021)
11.2 India Duchenne Muscular Dystrophy Sales Breakdown by Type
11.2.1 India Duchenne Muscular Dystrophy Sales Breakdown by Type (2016-2021)
11.2.2 India Duchenne Muscular Dystrophy Sales Breakdown by Type (2022-2027)
11.3 India Duchenne Muscular Dystrophy Sales Breakdown by Application
11.3.1 India Duchenne Muscular Dystrophy Sales Breakdown by Application (2016-2021)
11.3.2 India Duchenne Muscular Dystrophy Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Duchenne Muscular Dystrophy Business
12.1 PTC Therapeutics
12.1.1 PTC Therapeutics Corporation Information
12.1.2 PTC Therapeutics Business Overview
12.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2016-2021)
12.1.4 PTC Therapeutics Duchenne Muscular Dystrophy Products Offered
12.1.5 PTC Therapeutics Recent Development
12.2 Sarepta Therapeutics
12.2.1 Sarepta Therapeutics Corporation Information
12.2.2 Sarepta Therapeutics Business Overview
12.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sarepta Therapeutics Duchenne Muscular Dystrophy Products Offered
12.2.5 Sarepta Therapeutics Recent Development
12.3 Others
12.3.1 Others Corporation Information
12.3.2 Others Business Overview
12.3.3 Others Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Others Duchenne Muscular Dystrophy Products Offered
12.3.5 Others Recent Development
…

13 Duchenne Muscular Dystrophy Manufacturing Cost Analysis
13.1 Duchenne Muscular Dystrophy Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Duchenne Muscular Dystrophy
13.4 Duchenne Muscular Dystrophy Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Duchenne Muscular Dystrophy Distributors List
14.3 Duchenne Muscular Dystrophy Customers

15 Market Dynamics
15.1 Duchenne Muscular Dystrophy Market Trends
15.2 Duchenne Muscular Dystrophy Drivers
15.3 Duchenne Muscular Dystrophy Market Challenges
15.4 Duchenne Muscular Dystrophy Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Duchenne Muscular Dystrophy Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Duchenne Muscular Dystrophy Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Duchenne Muscular Dystrophy Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Duchenne Muscular Dystrophy Sales (K Doses) by Region (2016-2021)
Table 5. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2016-2021)
Table 6. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Duchenne Muscular Dystrophy Revenue Share by Region (2016-2021)
Table 8. Global Duchenne Muscular Dystrophy Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Duchenne Muscular Dystrophy Revenue Share Forecast by Region (2022-2027)
Table 12. Global Duchenne Muscular Dystrophy Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Duchenne Muscular Dystrophy Sales Share by Company (2016-2021)
Table 14. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Duchenne Muscular Dystrophy Revenue Share by Company (2016-2021)
Table 16. Global Duchenne Muscular Dystrophy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Duchenne Muscular Dystrophy as of 2020)
Table 17. Global Duchenne Muscular Dystrophy Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Duchenne Muscular Dystrophy Manufacturing Sites and Area Served
Table 19. Manufacturers Duchenne Muscular Dystrophy Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Duchenne Muscular Dystrophy Sales (K Doses) by Type (2016-2021)
Table 22. Global Duchenne Muscular Dystrophy Sales Share by Type (2016-2021)
Table 23. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Type (2016-2021)
Table 25. Global Duchenne Muscular Dystrophy Sales Share by Type (2022-2027)
Table 26. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Duchenne Muscular Dystrophy Revenue Share by Type (2022-2027)
Table 28. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Type (2022-2027)
Table 29. Global Duchenne Muscular Dystrophy Sales (K Doses) by Application (2016-2021)
Table 30. Global Duchenne Muscular Dystrophy Sales Share by Application (2016-2021)
Table 31. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Application (2016-2021)
Table 33. Global Duchenne Muscular Dystrophy Sales (K Doses) by Application (2022-2027)
Table 34. Global Duchenne Muscular Dystrophy Sales Share by Application (2022-2027)
Table 35. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Duchenne Muscular Dystrophy Revenue Share by Application (2022-2027)
Table 37. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Application (2022-2027)
Table 38. North America Duchenne Muscular Dystrophy Sales (K Doses) by Company (2016-2021)
Table 39. North America Duchenne Muscular Dystrophy Sales Market Share by Company (2016-2021)
Table 40. North America Duchenne Muscular Dystrophy Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Duchenne Muscular Dystrophy Revenue Market Share by Company (2016-2021)
Table 42. North America Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses)
Table 43. North America Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021)
Table 44. North America Duchenne Muscular Dystrophy Sales by Type (2022-2027) & (K Doses)
Table 45. North America Duchenne Muscular Dystrophy Sales Market Share by Type (2022-2027)
Table 46. North America Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses)
Table 47. North America Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021)
Table 48. North America Duchenne Muscular Dystrophy Sales by Application (2022-2027) & (K Doses)
Table 49. North America Duchenne Muscular Dystrophy Sales Market Share by Application (2022-2027)
Table 50. Europe Duchenne Muscular Dystrophy Sales (K Doses) by Company (2016-2021)
Table 51. Europe Duchenne Muscular Dystrophy Sales Market Share by Company (2016-2021)
Table 52. Europe Duchenne Muscular Dystrophy Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Duchenne Muscular Dystrophy Revenue Market Share by Company (2016-2021)
Table 54. Europe Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021)
Table 56. Europe Duchenne Muscular Dystrophy Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Duchenne Muscular Dystrophy Sales Market Share by Type (2022-2027)
Table 58. Europe Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021)
Table 60. Europe Duchenne Muscular Dystrophy Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Duchenne Muscular Dystrophy Sales Market Share by Application (2022-2027)
Table 62. China Duchenne Muscular Dystrophy Sales (K Doses) by Company (2016-2021)
Table 63. China Duchenne Muscular Dystrophy Sales Market Share by Company (2016-2021)
Table 64. China Duchenne Muscular Dystrophy Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Duchenne Muscular Dystrophy Revenue Market Share by Company (2016-2021)
Table 66. China Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses)
Table 67. China Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021)
Table 68. China Duchenne Muscular Dystrophy Sales by Type (2022-2027) & (K Doses)
Table 69. China Duchenne Muscular Dystrophy Sales Market Share by Type (2022-2027)
Table 70. China Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses)
Table 71. China Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021)
Table 72. China Duchenne Muscular Dystrophy Sales by Application (2022-2027) & (K Doses)
Table 73. China Duchenne Muscular Dystrophy Sales Market Share by Application (2022-2027)
Table 74. Japan Duchenne Muscular Dystrophy Sales (K Doses) by Company (2016-2021)
Table 75. Japan Duchenne Muscular Dystrophy Sales Market Share by Company (2016-2021)
Table 76. Japan Duchenne Muscular Dystrophy Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Duchenne Muscular Dystrophy Revenue Market Share by Company (2016-2021)
Table 78. Japan Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021)
Table 80. Japan Duchenne Muscular Dystrophy Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Duchenne Muscular Dystrophy Sales Market Share by Type (2022-2027)
Table 82. Japan Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021)
Table 84. Japan Duchenne Muscular Dystrophy Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Duchenne Muscular Dystrophy Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Duchenne Muscular Dystrophy Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Duchenne Muscular Dystrophy Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Duchenne Muscular Dystrophy Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Duchenne Muscular Dystrophy Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Duchenne Muscular Dystrophy Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Application (2022-2027)
Table 98. India Duchenne Muscular Dystrophy Sales (K Doses) by Company (2016-2021)
Table 99. India Duchenne Muscular Dystrophy Sales Market Share by Company (2016-2021)
Table 100. India Duchenne Muscular Dystrophy Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Duchenne Muscular Dystrophy Revenue Market Share by Company (2016-2021)
Table 102. India Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses)
Table 103. India Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021)
Table 104. India Duchenne Muscular Dystrophy Sales by Type (2022-2027) & (K Doses)
Table 105. India Duchenne Muscular Dystrophy Sales Market Share by Type (2022-2027)
Table 106. India Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses)
Table 107. India Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021)
Table 108. India Duchenne Muscular Dystrophy Sales by Application (2022-2027) & (K Doses)
Table 109. India Duchenne Muscular Dystrophy Sales Market Share by Application (2022-2027)
Table 110. PTC Therapeutics Corporation Information
Table 111. PTC Therapeutics Description and Business Overview
Table 112. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. PTC Therapeutics Duchenne Muscular Dystrophy Product
Table 114. PTC Therapeutics Recent Development
Table 115. Sarepta Therapeutics Corporation Information
Table 116. Sarepta Therapeutics Description and Business Overview
Table 117. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Sarepta Therapeutics Duchenne Muscular Dystrophy Product
Table 119. Sarepta Therapeutics Recent Development
Table 120. Others Corporation Information
Table 121. Others Description and Business Overview
Table 122. Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Others Duchenne Muscular Dystrophy Product
Table 124. Others Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Duchenne Muscular Dystrophy Distributors List
Table 128. Duchenne Muscular Dystrophy Customers List
Table 129. Duchenne Muscular Dystrophy Market Trends
Table 130. Duchenne Muscular Dystrophy Market Drivers
Table 131. Duchenne Muscular Dystrophy Market Challenges
Table 132. Duchenne Muscular Dystrophy Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Duchenne Muscular Dystrophy Product Picture
Figure 2. Global Duchenne Muscular Dystrophy Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Duchenne Muscular Dystrophy Sales Market Share by Application in 2021 & 2027
Figure 6. Male Examples
Figure 7. Female Examples
Figure 8. Global Duchenne Muscular Dystrophy Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Duchenne Muscular Dystrophy Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Duchenne Muscular Dystrophy Sales (K Doses) Growth Rate (2016-2027)
Figure 11. Global Duchenne Muscular Dystrophy Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 12. Global Duchenne Muscular Dystrophy Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Duchenne Muscular Dystrophy Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Duchenne Muscular Dystrophy Sales (K Doses) Growth Rate (2016-2027)
Figure 16. Europe Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Duchenne Muscular Dystrophy Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Duchenne Muscular Dystrophy Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Duchenne Muscular Dystrophy Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Duchenne Muscular Dystrophy Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Duchenne Muscular Dystrophy Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Duchenne Muscular Dystrophy Players Market Share by Revenue in Duchenne Muscular Dystrophy: 2016 & 2020
Figure 27. Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Duchenne Muscular Dystrophy Revenue Share by Type (2016-2021)
Figure 29. Global Duchenne Muscular Dystrophy Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Duchenne Muscular Dystrophy Revenue Share by Application (2016-2021)
Figure 31. Global Duchenne Muscular Dystrophy Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Duchenne Muscular Dystrophy Sales Market Share by Type in 2020
Figure 33. North America Duchenne Muscular Dystrophy Sales Market Share by Application in 2020
Figure 34. Europe Duchenne Muscular Dystrophy Sales Market Share by Type in 2020
Figure 35. Europe Duchenne Muscular Dystrophy Sales Market Share by Application in 2020
Figure 36. China Duchenne Muscular Dystrophy Sales Market Share by Type in 2020
Figure 37. China Duchenne Muscular Dystrophy Sales Market Share by Application in 2020
Figure 38. Japan Duchenne Muscular Dystrophy Sales Market Share by Type in 2020
Figure 39. Japan Duchenne Muscular Dystrophy Sales Market Share by Application in 2020
Figure 40. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Type in 2020
Figure 41. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Application in 2020
Figure 42. India Duchenne Muscular Dystrophy Sales Market Share by Type in 2020
Figure 43. India Duchenne Muscular Dystrophy Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Duchenne Muscular Dystrophy
Figure 46. Manufacturing Process Analysis of Duchenne Muscular Dystrophy
Figure 47. Duchenne Muscular Dystrophy Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size, Status and Forecast 2021-2027
QFJ1-5718 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、デュシェンヌ型筋ジストロフィー(DMD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エテプリルセン、デフラザコート、アタルレン）、用途別市場規模（病院、診療所、ホームケア）、主要地域別市場規...

世界の網膜ジストロフィー治療市場規模・現状・予測（2021年-2027年）

Global Retinal Dystrophy Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4827 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、網膜ジストロフィー治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子治療、対症療法）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy (SMA) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4894 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の脊髄性筋萎縮症（SMA）治療市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5351 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヌシネルセン、オナセムノゲンアベパルボベック）、用途別市場規模（タイプ1SMA、タイプ2 SMA、その他）、主要地域別市場規...

世界の脊髄性筋萎縮症遺伝子検出市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy Genetic Detection Market Size, Status and Forecast 2021-2027
QFJ1-4895 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症遺伝子検出の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、発症前検査）、用途別市場規模（病院、クリニック、診断センター）...

世界の球脊髄性筋萎縮症治療市場規模・現状・予測（2021年-2027年）

Global Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6018 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、球脊髄性筋萎縮症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5α-レダクターゼ阻害剤、ゴナドトロピン放出ホルモンアゴニスト）、用途別市場規模（病院、整形外科クリニック、外来手術センター）、主要...

旅行者下痢症治療薬のグローバル市場2021

Global Traveler's Diarrhea Therapeutics Sales Market Report 2021
QAF27913 2021年4月22日 135Pages
本市場調査資料では、世界の旅行者下痢症治療薬市場について種類別（予防接種、非抗生物質、抗生物質、抗運動剤、その他）、用途別（成人旅行者下痢症、子供旅行者下痢症）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販...

世界の神経変性疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Neurodegenerative Disorder Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5879 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、神経変性疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫調節剤、インターフェロン、デカルボキシラーゼ阻害剤、ドーパミン作動薬、その他）、用途別市場規模（多発性硬化症、パーキンソン病、アル...

世界のアテローム性動脈硬化症治療薬市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5602 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小分子、生物製剤）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の成長/分化係数8市場規模・現状・予測（2021年-2027年）

Global Growth/Differentiation Factor 8 Market Size, Status and Forecast 2021-2027
QFJ1-5763 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、成長/分化係数8の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OSX-200、SRK-015、ACE-2494、ACE-2798、BMS-986089、その他）、用途別市場規模（ベッカー筋ジストロフ...

世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drugs for Duchenne Muscular Dystrophy (DMD) Market The global Drugs for Duchenne Muscular Dystrophy (DMD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年） Spinal Muscular Atrophy (SMA), also known as spinal muscular atrophy, is a type of disease in which the degeneration of motor neurons in the anterior horn of the spinal cord leads to muscle weakness and muscular atrophy.The Spinal muscular atrophy drugs Can effectively alleviate the symptoms of the …
世界の網膜ジストロフィー治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Retinal Dystrophy Treatment Market The global Retinal Dystrophy Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界の脊髄性筋萎縮症（SMA）治療市場規模・現状・予測（2021年-2027年） Spinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy through the gene therapy drug called Zolgensma…
世界の脊髄性筋萎縮症遺伝子検出市場規模・現状・予測（2021年-2027年） A detection method for Spinal Muscular Atrophy Market Analysis and Insights: Global Spinal Muscular Atrophy Genetic Detection Market The global Spinal Muscular Atrophy Genetic Detection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…